Hi-Tech Pharmacal Co.'s (HITK) share price has entered into oversold territory with a stochastic value of 19.73. The Zacks Consensus Estimate on the company's earnings for April 2011 increased by 32 cents over the past two months to $2.69 per share. Hi-Tech Pharmacal Co. is a Zacks #1 Rank (“Strong Buy”) company.
HI TECH PHARMA (HITK): Free Stock Analysis Report
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsHI TECH PHARMA (HITK): Free Stock Analysis Report
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Health CarePharmaceuticals
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
